Hello everyone, am I studying Molecular Medicine in Freiburg and work at  a biochemistry laboratory. The lab focuses on protein structure and protein interactions with one another. The lab project I am currently enrolled in aims on understanding one specific interaction of a scaffold protein with an urat transporter, because mutations in this protein have shown an increased urat concentration in the blood which results in a lower risk of getting gout.  I am always eager to learn more about other lab projects and newest breakthrough in biomedicine.

Biotechnologist with a strong commitment to research and innovation. Completed an esteemed MSc in Biotechnology at IST with a notable grade of 19/20, coupled with research experiences at TUM, Munich, and ITQB, Oeiras. Also hold a BSc in Biochemistry from FCUL with a commendable grade of 17/20. Previous industry exposure at Johnson & Johnson has reinforced dedication to advancing biotechnology for a healthier world. Currently pursuing a PhD at Gulbenkian Institute of Molecular Medicine at FMUL, focusing on developing targeted cancer therapies. Research involves bioinformatics-driven drug design to target receptors overexpressed in cancer cells, alongside the development and testing of patient-derived spheroids. Dedicated to contributing to a future where diseases are overcome through innovative approaches.

Dr. Petar Ozretić is a Senior Research Associate and Head of the Laboratory for Hereditary Cancer at the Ruđer Bošković Institute (RBI) in Zagreb, Croatia. After receiving a Diploma degree in Molecular Biology at the Faculty of Science, University of Zagreb in 2005, he was employed as a Professional Associate at the RBI in 2006. Under the mentorship of Prof. Sonja Levanat and Prof. Alberto Inga, he obtained a PhD degree in Biomedicine and Health in 2013. He was a Senior Assistant at the RBI until 2017 when he was promoted to a Research Associate. He is an Adjunct Assistant Professor at the JJ Strossmayer University of Osijek from 2018. He mentored one PhD and seven Diploma theses. He was participating in 25 projects as an associate or PI. His research interests include regulation of the Hedgehog signaling pathway by ncRNAs, interaction between SHH protein and sex hormone receptors, and the role of m1A RNA modification in head and neck tumors. He is a member of the Editorial Council of Libri Oncologioci Croatian Journal of Oncology, a Technical Editor of Periodicum biologoum journal, reviewer for numerous journals (reviewed more than 700 manuscripts). He has published 58 scientific articles, which have been cited ~1500 times (Google Scholar's H-index 20). He is a member of 10 professional associations, and from 2009 he is a Secretary of the Croatian Association for Cancer Research (HDIR), national society affiliated to the European Association for Cancer Research (EACR).

Here: https://albruzos.github.io/about/